HomeNewscoronavirusGreater efforts needed to get routine immunization back to pre-Covid times: WHO

Greater efforts needed to get routine immunization back to pre-Covid times: WHO

New Delhi, July 16 The World Health Organization on Saturday called for greater efforts in the South-East Asia Region to revive routine immunization..

July 16, 2022 / 15:43 IST
AY.4.2 contains mutations that might give the virus survival advantages

The World Health Organization on July 16 called for greater efforts in the South-East Asia Region to revive routine immunization rates to pre-Covid times, stressing that despite concerted efforts by countries, challenges and gaps persist.

"Commendably the region has administered 3 billion doses of COVID-19 vaccines to date, since January 2021 when the first dose of vaccine was administered in the South-East Asia Region. As we focus on further scaling up COVID-19 vaccination coverage, we must also do all we can to ensure no child is deprived of life-saving vaccines offered under routine immunization services," said Dr Poonam Khetrapal Singh, Regional Director WHO South-East Asia.

Many counties have demonstrated that routine immunization can be maintained or scaled up along with COVID-19 vaccination, she said in a statement. "This speaks to a very committed health work force which has to manage both considerable challenges." Bangladesh, Maldives, Sri Lanka and Thailand maintained high vaccination rates over 95 per cent DTP3 coverage throughout the COVID-19 pandemic.

Bhutan witnessed a slight decline in 2020 but surpassed its pre-pandemic coverage of 97 per cent to record 98 per cent DTP3 coverage in 2021, it said. Globally, DTP3 (third dose of vaccines for diphtheria, tetanus and pertussis) in one-year old children, is a proxy indicator for immunization coverage, it said.

Nepal substantially revived routine immunization coverage for DTP3 from 84 per cent in 2020 to 91 per cent in 2021. These six countries have also achieved high COVID-19 vaccination coverage, the WHO statement said. Routine immunization coverage declines witnessed in 2020 in India and Timor-Leste seem to have stabilized in 2021 indicating programme recoveries as well, it said. R

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

In 2021, India provided close to 2 billion doses of COVID-19 and other childhood vaccines taken together, over five times more vaccines administered in the country during the year than in 2020, the statement said. All countries in the South-East Asia Region focused on routine immunization while prioritizing essential services during the pandemic and concerted efforts continue to be made to scale-up vaccination coverage, with a focus on identifying and vaccinating 'missed children' the world health body said.

Efforts for measles and rubella elimination, a flagship priority in the Region, continued during the pandemic. Nepal substantially increased the coverage for second dose of measles and rubella vaccine from 76 per cent in 2019 to 87 per cent in 2021. Bangladesh, Bhutan, Maldives, and Sri Lanka maintained their respective coverage rates throughout the pandemic, the statement said. To revitalize routine immunization coverage following the COVID-19 pandemic, WHO convened a South-East Asia Regional Working Group on Immunization in March this year focusing on programme intensification, it said.

Strengthening catch-up campaigns, tracking unvaccinated and under vaccinated children, combining COVID-19 vaccination with routine immunization, training of health workers and addressing concerns of communities, were stressed, the statement said. However, concerns and challenges remain, it added.

"WHO is cognizant of the efforts and is supporting Member States to improve routine immunization coverage. With stepped up efforts in recent months, we hope to see a speedy scale-up of DTP3 coverage to the pre-pandemic level of 91 per cent in 2019 from 82 per cent in 2021 and second dose measles and rubella vaccine coverage to beyond 83 per cent in 2019 from 78 per cent in 2021," the Regional Director said.

PTI
first published: Jul 16, 2022 03:43 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347